Cosmetic Label Compliance & Claims
The line that matters in cosmetics is not what your product does. It is what you say it does — and the same cream can be a cosmetic or an unapproved drug depending on the sentence.
Short answer
A cosmetic label needs an identity statement, net contents, the ingredient list by INCI name in descending order of concentration, any required warnings, and the name and address of the responsible party. Markets differ substantially beyond that: the EU requires a designated Responsible Person, a Product Information File, safety assessment, and CPNP notification before a product can be placed on the market, and typically a period-after-opening symbol. The decisive issue everywhere is claims. A cosmetic cleanses, beautifies, or alters appearance. A product claiming to affect the structure or function of the body — regenerating tissue, treating acne, reversing damage at a cellular level — is making a drug claim, and the product becomes an unapproved drug regardless of what the ingredient list says.
What the label must carry
Baseline elements, with the caveat that specifics vary by market and this is not legal advice:
- Identity — what the product is, in plain terms.
- Net contents — weight or volume, on the principal display panel.
- Ingredient list — INCI names, in descending order of concentration. Ingredients at or below one percent may generally be listed in any order after those above it, and colorants are handled separately.
- Warnings — where the product or an ingredient requires them.
- Responsible party — name and address of the manufacturer, packer, or distributor.
- Period after opening or shelf life — required in the EU and expected in several other markets.
INCI is not optional and not interchangeable with trade names. It is the international standard that lets a consumer with an allergy, and a regulator, read the same list and understand it.
Cosmetic claim or drug claim
| Cosmetic claim | Drug claim | |
|---|---|---|
| What it does | Cleanses, beautifies, alters appearance | Affects structure or function of the body |
| Aging | Reduces the appearance of fine lines | Reverses skin aging at a cellular level |
| Acne | Helps clarify the look of blemish-prone skin | Treats acne |
| Barrier | Helps skin feel moisturised and comfortable | Repairs the skin barrier |
| Pigment | Improves the look of uneven tone | Inhibits melanin production to treat hyperpigmentation |
| Consequence | Regulated as a cosmetic | Regulated as a drug; unapproved unless it went through that pathway |
The pattern: appearance language keeps you in cosmetics; mechanism and treatment language moves you out. "Reduces the appearance of" is doing real regulatory work, not hedging.
Market differences that change the product
European Union
The most demanding of the major frameworks, and it constrains the formula rather than only the label. A designated Responsible Person established in the EU, a Product Information File, a safety assessment by a qualified assessor, and CPNP notification are all required before the product can be placed on the market. There are also extensive restricted and prohibited ingredient lists, and permitted preservatives and concentrations are specified.
If the EU is a target market, it belongs in the brief at formulation, because a formula built without those lists may simply not be sellable there.
United States
Historically lighter-touch than the EU, with a stronger emphasis on the cosmetic-versus-drug boundary and on ingredient safety being the manufacturer's responsibility. Facility registration and product listing obligations have been expanding, so treat any guide's description of current requirements — including this one — as a prompt to check rather than a substitute for checking.
Other markets
India, the Gulf, and much of Asia each maintain their own registration and ingredient rules, and some require in-market registration before import. Pick your markets before you formulate. A formula that is fine in one and prohibited in another is a discovery best made before production rather than at customs.
Where cosmetic brands get caught
- Marketing that is more ambitious than the label, on a website or in an ad. The analysis covers everything you publish.
- Before-and-after imagery implying treatment of a condition rather than change in appearance.
- Ingredient-led claims that describe a biological mechanism, which is drug language even when the ingredient is common.
- Influencer content describing outcomes, produced from a brief you supplied.
- Selling into the EU without a Responsible Person, a safety assessment, or notification in place.
- INCI lists that do not match the formula actually manufactured, usually after a late reformulation.
Not legal advice: this page describes how the categories work so you can brief a professional efficiently. Have the final label, the claims, and any market registration reviewed by a qualified regulatory specialist.
Frequently asked questions
Can I say my serum is anti-aging?
Generally yes as appearance language — reduces the appearance of fine lines and wrinkles. What moves it into drug territory is claiming to reverse aging, regenerate tissue, or act at a cellular level. The words are doing regulatory work, and choosing them carefully is not evasion, it is the difference between two regulatory categories.
Do I need a safety assessment?
For the EU, yes — it is a requirement before placing a product on the market, and it forms part of the Product Information File. Elsewhere it may not be mandatory but is increasingly expected by serious retail and export buyers, and it is a reasonable standard to hold yourself to regardless.
Does the ingredient order on my label matter?
Yes. INCI names in descending order of concentration is the requirement, with ingredients at or below one percent generally permitted in any order after those above. Getting the order wrong is a compliance problem and it also misleads consumers who read the list to judge whether an active is present meaningfully.
How does Formulaite help with cosmetic compliance?
By screening ingredient status and claim support against the markets you intend to sell into while the formula can still change — including EU restricted lists and preservative limits, which constrain the formula rather than just the label. It is a screening step designed to surface problems early, not a substitute for the professional review at the end.
Related founder resources
Screen the claim before you print the tube
Formulaite checks ingredient status and claim support across the markets you are selling into, at the point where the formula can still change.